Insider · CIK 0001579872

Patel Mahesh V.

Reports to the SEC for 1 company · SALT LAKE CITY, UT

sec.gov

Transactions

Companies

Filings

CIK

0001579872

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-29	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+52.8K sh	$2.49	+$131K	227,214
2026-04-06	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+25K sh	$2.03	+$50.7K	160,679
2026-04-02	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+25K sh	$2.02	+$50.5K	135,679
2026-01-02	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+25K sh	$8.00	+$200K	182,668
2025-12-18	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+8,629 sh	$4.20	+$36.2K	157,668
2025-01-02	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+16.4K sh	$4.86	+$79.6K	149,039
2024-12-23	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+26.7K sh	$4.80	+$128K	149,039
2024-12-23	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+10.3K sh	$4.80	+$49.5K	132,688
2024-03-08	LPCNLipocine Inc.A Award	Director, Chief Executive Officer	AAward	+4,893 sh	—	—	112,311
2023-05-25	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+8,706 sh	$5.03	+$43.8K	107,418
2023-03-24	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+150K sh	$0.32	+$48K	1,678,090
2023-03-17	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+50K sh	$0.33	+$16.5K	1,528,090
2023-01-03	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	$0.41	+$123K	2,542,395
2022-12-22	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+113K sh	$0.41	+$46.1K	2,242,395
2022-11-14	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+75K sh	$0.39	+$29.3K	1,478,090
2022-09-27	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+100K sh	$0.41	+$41K	1,403,090
2022-05-16	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+50K sh	$0.77	+$38.5K	1,303,090
2022-01-03	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+288K sh	$1.09	+$313K	287,500
2021-12-07	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+125K sh	$1.12	+$140K	125,000
2021-11-18	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+25K sh	$1.09	+$27.3K	1,253,090
2021-01-04	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+275K sh	$1.43	+$393K	275,000
2020-12-28	LPCNLipocine Inc. · Stock Option (Right to Buy)J Other	Director, Chief Executive Officer	JOther	−275K sh	—	—	100,000
2020-12-16	LPCNLipocine Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+45K sh	—	—	1,243,090
2020-12-16	LPCNLipocine Inc.S Sale	Director, Chief Executive Officer	SSale	−15K sh	$1.35	−$20.3K	1,228,090
2020-12-16	LPCNLipocine Inc. · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+45K sh	—	—	45,000
2020-12-15	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+375K sh	$1.37	+$514K	375,000
2020-12-05	LPCNLipocine Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+123K sh	—	—	1,198,090
2020-12-05	LPCNLipocine Inc. · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−123K sh	—	—	122,978
2020-12-04	LPCNLipocine Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+145K sh	—	—	1,118,612
2020-12-04	LPCNLipocine Inc.S Sale	Director, Chief Executive Officer	SSale	−43.5K sh	$1.57	−$68.1K	1,075,112
2020-12-04	LPCNLipocine Inc. · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−145K sh	—	—	145,000
2020-01-28	LPCNLipocine Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	$0.46	+$137K	300,000
2019-12-31	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+40K sh	$0.38	+$15.3K	973,612
2019-12-10	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+25K sh	$0.40	+$9,975	933,612
2019-12-05	LPCNLipocine Inc. · Restricted Stock UnitA Award	Director, Chief Executive Officer	AAward	+123K sh	—	—	122,978
2019-12-04	LPCNLipocine Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+145K sh	—	—	952,112
2019-12-04	LPCNLipocine Inc.S Sale	Director, Chief Executive Officer	SSale	−43.5K sh	$0.41	−$17.8K	908,612
2019-12-04	LPCNLipocine Inc. · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−145K sh	—	—	145,000
2019-11-26	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,272 sh	$0.43	+$542.508	783,384
2019-11-26	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+700 sh	$0.43	+$298.62	784,084
2019-11-26	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,100 sh	$0.43	+$469.7	785,184
2019-11-26	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+21.9K sh	$0.43	+$9,385.184	807,112
2019-11-18	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4,931 sh	$0.40	+$1,971.907	737,043
2019-11-18	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+40.3K sh	$0.40	+$16.1K	777,302
2019-11-18	LPCNLipocine Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4,810 sh	$0.42	+$2,019.238	782,112
2019-05-24	LPCNLipocine Inc.A Award	Director, Chief Executive Officer	AAward	+4,527 sh	$1.58	+$7,152.66	726,639
2019-05-24	LPCNLipocine Inc.A Award	Director, Chief Executive Officer	AAward	+2,500 sh	$1.59	+$3,975	729,139
2019-05-24	LPCNLipocine Inc.A Award	Director, Chief Executive Officer	AAward	+473 sh	$1.60	+$756.8	729,612
2019-05-24	LPCNLipocine Inc.A Award	Director, Chief Executive Officer	AAward	+2,500 sh	$1.64	+$4,100	732,112
2018-12-04	LPCNLipocine Inc. · Restricted stock unitA Award	Director, Chief Executive Officer	AAward	+290K sh	—	—	290,000

Recent filings

Accepted (ET)
Jun 304
Patel Mahesh V.0001493152-26-031377
SEC(opens sec.gov)
Apr 64
Patel Mahesh V.0001493152-26-015357
SEC(opens sec.gov)
Apr 24
Patel Mahesh V.0001493152-26-014959
SEC(opens sec.gov)
Jan 54
Patel Mahesh V.0001493152-26-000361
SEC(opens sec.gov)
Dec 194
Patel Mahesh V.0001493152-25-028597
SEC(opens sec.gov)
Jan 24
Patel Mahesh V.0001493152-25-000121
SEC(opens sec.gov)
Jan 24/A
Patel Mahesh V.0001493152-25-000123
SEC(opens sec.gov)
Dec 304
Patel Mahesh V.0001493152-24-052577
SEC(opens sec.gov)
Mar 124
Patel Mahesh V.0001493152-24-009707
SEC(opens sec.gov)
May 254
Patel Mahesh V.0001493152-23-019050
SEC(opens sec.gov)
Mar 244
Patel Mahesh V.0001493152-23-008943
SEC(opens sec.gov)
Mar 174
Patel Mahesh V.0001493152-23-008087
SEC(opens sec.gov)
Jan 44
Patel Mahesh V.0001493152-23-000274
SEC(opens sec.gov)
Dec 224
Patel Mahesh V.0001493152-22-036373
SEC(opens sec.gov)
Nov 144
Patel Mahesh V.0001493152-22-031971
SEC(opens sec.gov)
Sep 274
Patel Mahesh V.0001493152-22-026945
SEC(opens sec.gov)
May 164
Patel Mahesh V.0001493152-22-014014
SEC(opens sec.gov)
Jan 34
Patel Mahesh V.0001493152-22-000154
SEC(opens sec.gov)
Dec 84
Patel Mahesh V.0001493152-21-030818
SEC(opens sec.gov)
Nov 184
Patel Mahesh V.0001493152-21-029268
SEC(opens sec.gov)

Companies

Lipocine Inc.Director, Chief Executive OfficerLPCN

Address

675 ARAPEEN DRIVE SUITE 202

SALT LAKE CITY, UT, 84108